Elite members get real-time data, technical charting, alerts, and no ads - starting at $24.96/mo.
Try Elite for Free
Last Close
12.32
Oct 22 • 3:59 PM ET Dollar change+0.48 Percentage change(4.10%)
Aftermarket Close
12.25
Aftermarket • 7:30 PM ET Dollar change-0.07 Percentage change(-0.61%)
Oct 21, 1:00 PMIntegra LifeSciences cuts 2026 outlook, lowers adjusted gross margin guidance by 60 bps after Cincinnati flood disruption
Index
RUT
Market Cap
958.55M
Enterprise Value
2.47B
Income
13.01M
Sales
1.66B
Book/sh
13.41
Cash/sh
4.01
Dividend Est.
-
Dividend TTM
-
Dividend Ex-Date
-
Dividend Gr. 3/5Y
- -
Payout
-
Employees
4427
IPO
Aug 16, 1995
P/E
74.92
Forward P/E
5.18
PEG
1.49
P/S
0.58
P/B
0.92
P/C
3.07
P/FCF
37.15
EV/EBITDA
7.16
EV/Sales
1.49
Quick Ratio
2.11
Current Ratio
3.60
Debt/Eq
1.71
LT Debt/Eq
1.71
Option/Short
Yes / Yes
EPS (ttm)
0.16
EPS next Y
2.38
EPS next Q
0.64
EPS this Y
5.06%
EPS next Y
1.64%
EPS next 5Y
3.48%
EPS past 3/5Y
- -
Sales past 3/5Y
1.63% 3.57%
EPS Y/Y TTM
98.56%
Sales Y/Y TTM
0.84%
EPS Q/Q
368.47%
Sales Q/Q
2.27%
Insider Own
14.48%
Insider Trans
0.00%
Inst Own
94.64%
Inst Trans
-1.64%
ROA
-0.20%
ROE
1.24%
ROIC
0.45%
Gross Margin
54.84%
Oper. Margin
11.67%
Profit Margin
0.79%
SMA20
-11.72%
SMA50
-20.33%
SMA200
-12.52%
Trades
Shs Outstand
77.77M
Shs Float
66.51M
52W High
20.49 -39.85%
52W Low
8.70 41.67%
Volatility
7.39% 5.47%
ATR (14)
0.82
RSI (14)
35.33
Beta
1.25
Rel Volume
1.46
Avg Volume
946.80K
Volume
1,386,986
Perf Week
-8.91%
Perf Month
-20.64%
Perf Quarter
-37.72%
Perf Half Y
19.43%
Perf YTD
-0.76%
Perf Year
-20.28%
Perf 3Y
-67.51%
Perf 5Y
-82.60%
Perf 10Y
-69.74%
Prev Close
11.84
Price
12.32
Change %
4.10%
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
Singh HarvinderEVP & PRESIDENT, INTERNATIONALMar 11 '26Option Exercise0.0018,922040,612Mar 12 06:10 PM
Singh HarvinderEVP & PRESIDENT, INTERNATIONALMar 10 '26Option Exercise0.001,216023,152Mar 12 06:10 PM
Poul MojdehPresident & CEOJan 06 '26Option Exercise0.001,39001,390Jan 07 04:10 PM
GRAVES JEFFREY ADirectorNov 05 '25Buy11.359,000102,15041,086Nov 06 04:05 PM
Integra LifeSciences Holdings Corp. engages in the provision of regenerative tissue technologies and neurological solutions dedicated to limiting uncertainty for clinicians. It operates under the Codman Specialty Surgical (CSS) and Tissue Technologies (TT) segments. The CSS segment includes technologies and instrumentation used for neurosurgery, neurocritical care, and otolaryngology. The TT segment focuses on complex wound surgery, surgical reconstruction, and peripheral nerve repair. The company was founded by Richard E. Caruso in 1989 and is headquartered in Princeton, NJ.
CEODr. Stuart M. Essig Ph.D.
Executive VP & CFOMs. Lea Daniels Knight
Executive Vice President of Tissue Reconstruction and Distributed TechnologiesMr. Robert T. Davis Jr.
Executive VP & Chief Commercial OfficerMr. Michael J. McBreen
Executive VP & President of International BusinessMr. Harvinder Pal Singh